Tecan Group AG 2021 AR2
The report highlights Tecan's successful fiscal year 2021, marked by the transformational acquisition of Paramit Corporation, which expanded its capabilities into medical devices. The company achieved double-digit sales growth, driven by both COVID-19 related demand and a recovery in its core life science research and diagnostics markets. On the sustainability front, Tecan established a Sustainability Committee, committed to the Science Based Targets initiative (SBTi) to set a net-zero target, and achieved a Great Place to Work certification in Switzerland. Additionally, the company successfully certified its first diagnostic assay under the European Union's In Vitro Diagnostic Regulation (IVDR).
Company: Tecan Group AG
Sector: Manufacturing
Country: Switzerland
Year: 2021
Type: AR2
Pages: 97
Tecan Group AG
The report highlights Tecan's successful fiscal year 2021, marked by the transformational acquisition of Paramit Corporation, which expanded its capabilities into medical devices. The company achieved double-digit sales growth, driven by both COVID-19 related demand and a recovery in its core life science research and diagnostics markets. On the sustainability front, Tecan established a Sustainability Committee, committed to the Science Based Targets initiative (SBTi) to set a net-zero target, and achieved a Great Place to Work certification in Switzerland. Additionally, the company successfully certified its first diagnostic assay under the European Union's In Vitro Diagnostic Regulation (IVDR).
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Employees